商務部:堅決反對美方濫用出口管制兼限制晶片貨物出口
英偉達(NVDA.US)及AMD(AMD.US)表示,美國官員要求公司停止向中國出口用於人工智能的高端晶片。商務部發言人束(王玉)婷表示,中方注意到美國對中國最新的晶片限制,一直以來美方不斷濫用出口管制措施,以及限制對中國出口晶片相關貨品,中方對此堅決反對。
她稱,美方相關做法背離公平競爭原則,違反國際經貿規則,不僅損害中國企業的正當權益,也將嚴重影響美國企業的利益,阻礙國際科技交流和經貿合作,對全球產業鏈供應鏈穩定和世界經濟恢復造成衝擊,美方應立即停止錯誤做法,公平對待包括中國企業在內的各國企業,多做有利於世界經濟穩定的事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.